Table 4 Summary of the DVH analysis for the organs at risk for the entire cohort of patients

Left kidney

174.2 ± 51.7 (123.2;218.7)

Mean (Gy)

1.5 ± 1.3

(0.1;3.3)

D_1cm3 (Gy)

3.5 ± 3.1

(0.1;6.9)

V_15Gy (%)

0.0 ± 0.0

(0.0;0.0)

Right kidney

182.3 ± 37.8 (135.8;213.1)

Mean (Gy)

2.8 ± 4.1

(0.1;8.8)

D_1cm3 (Gy)

10.6 ± 12.3

(0.2;25.1)

V_15Gy (%)

4.1 ± 7.2

(0.0;14.8)

Spine

22.7 ± 7.2 (9.9;35.6)

D_1cm3 (Gy)

8.2 ± 4.5

(1.9;16.7)

Stomach

174.8 ± 117.2 (76.3;473.2)

Mean (Gy)

4.5 ± 3.0

(3.0;36.6)

D_1cm3 (Gy)

9.2 ± 5.8

(0.3;22.4)

V_37.5Gy (%)

0.0 ± 0.0

(0.0;0.0)

Esophagus

10.3 ± 6.3 (4.8;21.7)

Mean (Gy)

5.9 ± 7.9

(0.1;19.4)

D_1% (Gy)

10.2 ± 9.7

(0.1;30.1)

V_50Gy (%)

0.0 ± 0.0

(0.0;0.0)

Liver-PTV

1242 ± 330 (780;1981)

Mean (Gy)

8.6 ± 4.6

(1.4;17.1)

(Healthy liver)

V < 15Gy (cm3)

995.2 ± 163.6

(667.6;1718.2)

V_30Gy (%)

24.4 ± 11.6

(0.6;56.4)

Total liver

1439 ± 386 (928;2197)

Mean (Gy)

13.3 ± 8.3

(2.7;32.9)

V_30Gy (%)

13.8 ± 12.1

(1.1;49.3)

Healthy tissue

20512 ± 5059 (11277;28676)

Mean (Gy)

2.5 ± 1.7

(0.5;7.3)

V_10Gy (%)

6.1 ± 4.6

(0.9;19.5)

DoseInt (Gy*cm³*10⁴)

6.3 ± 2.7

(0.1;14.2)